Trump to discuss the results of the new autism after hinting to the main discovery during Kirk Memorial

In the Charlie Kerk Memorial Monument, the President Donald Trump He deviated outside the half to reveal that his administration revealed new results on autism. He suggested that the upcoming public health surrounds will examine the potential links between acetaminophen, which are widely sold in the name of Tilanol, and the Autism spectrum disorder (ASD).

Reports indicate that Trump’s statements may also extend to the warning of pregnant women about the use of routine acetaminophen, indicating a controversial shift in health directives that may cause discussion at the country level.

It is expected to highlight Trump’s planned comments, which is a drug that is traditionally used for anemia and some cancerous treatments, as a potential treatment aimed at improving communication skills in children with autism.

The briefing will be attended by Minister of Health Robert F. Kennedy Junior, FDA Commissioner Marti Macari and CMS Mohamed Oz manager.

The background: Taylinol research and autism

This advertisement reaches the increasing public interest in the environmental and pharmaceutical factors that contribute to autism. Tilanol, or acetaminophen, is widely used during pregnancy to reduce fever and manage pain.

Some studies they have A possible association Between exposure to before birth and growth disorders, although the results are still not decisive.

Autistic diagnoses in the United States have increased over the past two decades. Data from Disease control and prevention centers It indicates that 1 in 31 years of age is diagnosed with autism, compared to 1 out of 150 in 2000.

The administration cited environmental toxins as a possible shareholder, while many experts assert that improving diagnosis and increasing awareness are likely to be major engines for increasing numbers.

The most prominent Leocovorin as a possible treatment for autism

In addition to caution from Tilanol, White House It is expected to focus on Leucovorin as a potential treatment. Early research indicates that the drug may improve communication and cognitive function in some children with autism.

Leucovorin is derived from folic acid and was traditional Used to treat some forms of anemia To deal with the side effects of chemotherapy.

Experts emphasize that the search for Leucovorin is still primarily. Clinical experiments are continuing, and scientists emphasize that the results must be interpreted with caution before widely recommended the drug as a standard treatment for autism.

Medical community raises concerns

The proposed guidance prompted anxiety among health professionals. Many doctors argue that current evidence does not support a final link between the use of acetaminophen in pregnancy and autism.

The American College of Obstetricians, Gynecology and the American Academy of Pediatrics continues to consider acetaminophen safe when taken as directed.

Kenvue, the manufacturer of a teelinol, issued a statement confirming that there is no conclusive evidence linking acetaminophen to autism.

Experts warn that general confusion over these allegations can lead to an unnecessary avoidance of potential health and health risks, especially when fever management is very important during pregnancy.

The effects of public health

Trump’s announcement is a noticeable shift in messages about the use of acetaminophen during pregnancy. Although guidance is not legally binding, it may affect public behavior, prenatal care and media coverage.

Health care providers are encouraged to discuss the risks and benefits with their patients and remain aware of continuous research.

Additional studies on both exposure to maytaminophen and potential autism treatments, including Leucovorin, are expected to be more clear in the coming years. Organizational agencies, including the Food and Drug Administration, are closely monitoring the situation to assess any amendments to politics.

It was originally published on Ibtimes UK